Loading…
Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis
Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemi...
Saved in:
Published in: | Molecular cancer therapeutics 2013-08, Vol.12 (8), p.1591-1604 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243 |
container_end_page | 1604 |
container_issue | 8 |
container_start_page | 1591 |
container_title | Molecular cancer therapeutics |
container_volume | 12 |
creator | Petruccelli, Luca A Pettersson, Filippa Del Rincón, Sonia V Guilbert, Cynthia Licht, Jonathan D Miller, Jr, Wilson H |
description | Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs. |
doi_str_mv | 10.1158/1535-7163.MCT-12-1039 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1420157396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1420157396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</originalsourceid><addsrcrecordid>eNo9kd9u1TAMxiPExMbgEUC55KYjTpo2vZwO44-0jZtxHaWJwwJtU-oUcR5hb03PzuDKlv2zLX8fY29AXABo8x600lULjbq42d1VICsQqnvGzra6qYyG-vljfmRO2UuiH0KA6SS8YKdSadW0sj1jD1d_5gWJUp54jnzA9SeOyVWOKPvkCgYe18fuvOSCaSKeJr-gIyROOFEq6Xcqe14yv09U8oQ8oPNY9sPGbPB96lPJS5WmsPpt3YfbSx7c6L4jd1Pgbs5zyZToFTuJbiB8_RTP2bePV3e7z9X1109fdpfXlVe6KZWpRStCC8ph53ulRB1bF4UHI0WtTV-bPhrfdRpNiACy9lKibjD6PrQoa3XO3h33bg_9WpGKHRN5HAY3YV7JQi0F6FZ1zYbqI-qXTLRgtPOSRrfsLQh7cMEeFLYHhe3mggVpDy5sc2-fTqz9iOH_1D_Z1V8AF4bL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1420157396</pqid></control><display><type>article</type><title>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Petruccelli, Luca A ; Pettersson, Filippa ; Del Rincón, Sonia V ; Guilbert, Cynthia ; Licht, Jonathan D ; Miller, Jr, Wilson H</creator><creatorcontrib>Petruccelli, Luca A ; Pettersson, Filippa ; Del Rincón, Sonia V ; Guilbert, Cynthia ; Licht, Jonathan D ; Miller, Jr, Wilson H</creatorcontrib><description>Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.</description><identifier>ISSN: 1535-7163</identifier><identifier>EISSN: 1538-8514</identifier><identifier>DOI: 10.1158/1535-7163.MCT-12-1039</identifier><identifier>PMID: 23536727</identifier><language>eng</language><publisher>United States</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Apoptosis - genetics ; Cell Line, Tumor ; DNA Damage - drug effects ; DNA Repair ; Drug Resistance, Neoplasm - genetics ; Gene Expression Regulation, Leukemic ; Histone Deacetylase Inhibitors - chemistry ; Histone Deacetylase Inhibitors - pharmacology ; Humans ; Hydroxamic Acids - chemistry ; Hydroxamic Acids - pharmacology ; Leukemia, Myeloid, Acute - genetics ; Oncogene Proteins, Fusion - genetics</subject><ispartof>Molecular cancer therapeutics, 2013-08, Vol.12 (8), p.1591-1604</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</citedby><cites>FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23536727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Petruccelli, Luca A</creatorcontrib><creatorcontrib>Pettersson, Filippa</creatorcontrib><creatorcontrib>Del Rincón, Sonia V</creatorcontrib><creatorcontrib>Guilbert, Cynthia</creatorcontrib><creatorcontrib>Licht, Jonathan D</creatorcontrib><creatorcontrib>Miller, Jr, Wilson H</creatorcontrib><title>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</title><title>Molecular cancer therapeutics</title><addtitle>Mol Cancer Ther</addtitle><description>Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - genetics</subject><subject>Cell Line, Tumor</subject><subject>DNA Damage - drug effects</subject><subject>DNA Repair</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Gene Expression Regulation, Leukemic</subject><subject>Histone Deacetylase Inhibitors - chemistry</subject><subject>Histone Deacetylase Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Hydroxamic Acids - chemistry</subject><subject>Hydroxamic Acids - pharmacology</subject><subject>Leukemia, Myeloid, Acute - genetics</subject><subject>Oncogene Proteins, Fusion - genetics</subject><issn>1535-7163</issn><issn>1538-8514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo9kd9u1TAMxiPExMbgEUC55KYjTpo2vZwO44-0jZtxHaWJwwJtU-oUcR5hb03PzuDKlv2zLX8fY29AXABo8x600lULjbq42d1VICsQqnvGzra6qYyG-vljfmRO2UuiH0KA6SS8YKdSadW0sj1jD1d_5gWJUp54jnzA9SeOyVWOKPvkCgYe18fuvOSCaSKeJr-gIyROOFEq6Xcqe14yv09U8oQ8oPNY9sPGbPB96lPJS5WmsPpt3YfbSx7c6L4jd1Pgbs5zyZToFTuJbiB8_RTP2bePV3e7z9X1109fdpfXlVe6KZWpRStCC8ph53ulRB1bF4UHI0WtTV-bPhrfdRpNiACy9lKibjD6PrQoa3XO3h33bg_9WpGKHRN5HAY3YV7JQi0F6FZ1zYbqI-qXTLRgtPOSRrfsLQh7cMEeFLYHhe3mggVpDy5sc2-fTqz9iOH_1D_Z1V8AF4bL</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Petruccelli, Luca A</creator><creator>Pettersson, Filippa</creator><creator>Del Rincón, Sonia V</creator><creator>Guilbert, Cynthia</creator><creator>Licht, Jonathan D</creator><creator>Miller, Jr, Wilson H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</title><author>Petruccelli, Luca A ; Pettersson, Filippa ; Del Rincón, Sonia V ; Guilbert, Cynthia ; Licht, Jonathan D ; Miller, Jr, Wilson H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - genetics</topic><topic>Cell Line, Tumor</topic><topic>DNA Damage - drug effects</topic><topic>DNA Repair</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Gene Expression Regulation, Leukemic</topic><topic>Histone Deacetylase Inhibitors - chemistry</topic><topic>Histone Deacetylase Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Hydroxamic Acids - chemistry</topic><topic>Hydroxamic Acids - pharmacology</topic><topic>Leukemia, Myeloid, Acute - genetics</topic><topic>Oncogene Proteins, Fusion - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petruccelli, Luca A</creatorcontrib><creatorcontrib>Pettersson, Filippa</creatorcontrib><creatorcontrib>Del Rincón, Sonia V</creatorcontrib><creatorcontrib>Guilbert, Cynthia</creatorcontrib><creatorcontrib>Licht, Jonathan D</creatorcontrib><creatorcontrib>Miller, Jr, Wilson H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular cancer therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petruccelli, Luca A</au><au>Pettersson, Filippa</au><au>Del Rincón, Sonia V</au><au>Guilbert, Cynthia</au><au>Licht, Jonathan D</au><au>Miller, Jr, Wilson H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</atitle><jtitle>Molecular cancer therapeutics</jtitle><addtitle>Mol Cancer Ther</addtitle><date>2013-08</date><risdate>2013</risdate><volume>12</volume><issue>8</issue><spage>1591</spage><epage>1604</epage><pages>1591-1604</pages><issn>1535-7163</issn><eissn>1538-8514</eissn><abstract>Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.</abstract><cop>United States</cop><pmid>23536727</pmid><doi>10.1158/1535-7163.MCT-12-1039</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1535-7163 |
ispartof | Molecular cancer therapeutics, 2013-08, Vol.12 (8), p.1591-1604 |
issn | 1535-7163 1538-8514 |
language | eng |
recordid | cdi_proquest_miscellaneous_1420157396 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Apoptosis - drug effects Apoptosis - genetics Cell Line, Tumor DNA Damage - drug effects DNA Repair Drug Resistance, Neoplasm - genetics Gene Expression Regulation, Leukemic Histone Deacetylase Inhibitors - chemistry Histone Deacetylase Inhibitors - pharmacology Humans Hydroxamic Acids - chemistry Hydroxamic Acids - pharmacology Leukemia, Myeloid, Acute - genetics Oncogene Proteins, Fusion - genetics |
title | Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A55%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20leukemia-associated%20fusion%20proteins%20increases%20sensitivity%20to%20histone%20deacetylase%20inhibitor-induced%20DNA%20damage%20and%20apoptosis&rft.jtitle=Molecular%20cancer%20therapeutics&rft.au=Petruccelli,%20Luca%20A&rft.date=2013-08&rft.volume=12&rft.issue=8&rft.spage=1591&rft.epage=1604&rft.pages=1591-1604&rft.issn=1535-7163&rft.eissn=1538-8514&rft_id=info:doi/10.1158/1535-7163.MCT-12-1039&rft_dat=%3Cproquest_cross%3E1420157396%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1420157396&rft_id=info:pmid/23536727&rfr_iscdi=true |